Joe Sinclair

A New Focus for Cancer Therapeutics

As oncolytic virotherapy comes into industry focus, a range of challenges including variable target virus selection, clinical patient access, and manufacturability require industry progress. Here, I share insights and crucial considerations to successful marketization.